featured
Efficacy, Durability, and Safety of Faricimab in Patients With Neovascular AMD From Asian Countries
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Graefe's Archive for Clinical and Experimental Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials
Graefes Arch. Clin. Exp. Ophthalmol 2023 Nov 01;261(11)3125-3137, K Takahashi, CMG Cheung, T Iida, TYY Lai, M Ohji, Y Yanagi, M Kawano, S Ohsawa, T Suzuki, A Kotecha, H Lin, V Patel, B Swaminathan, WK LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.